May 2006 Research News
Few Women Have Regrets When Choosing Preventive Mastectomy for Other Breast
Most women who have preventive mastectomy are satisfied with their choice. They don't have any regrets and have a good quality of life, according to this study. Read more…
Taxotere and Herceptin Reduces Recurrence of Early-Stage Breast Cancer
In women with early-stage breast cancer, Taxotere (chemical name: docetaxel) significantly improved disease-free survival, compared to Navelbine (chemical name: vinorelbine). In women with early-stage HER2-positive breast cancer, disease-free survival was better in women who received Herceptin, compared to women who did not. Read more…
First Guidelines Created for Treating Early-Stage Breast Cancer During Pregnancy
The National Comprehensive Cancer Network (NCCN), a group of 19 leading cancer institutions in the United States that develop guidelines for treatment of all types of cancer, created guidelines for treatment of early-stage breast cancer during pregnancy. Read more…
Commercial Tests Don't Find All Breast Cancer-Related Genetic Abnormalities in Families at Very High Risk
Among women and men with breast cancer who have a strong family history of breast or ovarian cancer and who test negative for abnormal breast cancer genes in commercial tests, about 12% can expect to have an undetected BRCA1 or BRCA2 abnormality. Read more…